510(k) Report

FDA applicant

Boehringer Mannheim Corp.

Indianapolis, IN341 decisions1976–199977 recalls

FDA records 341 decisions for Boehringer Mannheim Corp. (Indianapolis, IN) from 1976 to 1999: 340 510(k) clearances and 1 original PMA approval. Most are in product codes JJX (Single (Specified) Analyte Controls (Assayed…) and CGA (Glucose Oxidase, Glucose). Its devices cite 89 predicates, 38 of them its own earlier devices. 77 recalls are linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, clinical chemistry panel, where it files most

How often FDA has decided Boehringer Mannheim Corp.’s devices, and how often a recall has named them.

FDA decisions per year

No FDA decision for Boehringer Mannheim Corp. since 2007.

Recalls per year

1in 2019

2007: 12008: 102009: 12012: 12014: 12015: 72016: 22017: 32018: 12019: 1
2007high 10 (2008) · low 0 (2010)2026

Class I Class II/III not classified

FIG. 1 — Boehringer Mannheim Corp. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Boehringer Mannheim Corp.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Boehringer”

FDA records each applicant name separately; these may or may not be the same firm.